By Michael Vlessides
Originally published by our sister publication, Gastroenterology Endoscopy News
The COVID-19 pandemic’s hindrance of global and regional efforts to eliminate hepatitis C likely will result in more than 70,000 additional liver-related deaths by the year 2030, a recent study found.
“When the COVID pandemic started, we didn’t really know what the full extent of disruptions was going to be across the spectrum of health care services,” said Sarah Blach, MHS,